Other Name(s): P53
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1
Value:=1390nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:Cc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C
Value:=3000nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:Cc1cc2c(cc1F)OC(c1ccc(Br)cc1)C1=C2N(C)c2ncnn2C1c1ccc(Br)cc1
Value:=11400nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(F)cc32)C(c2ccc(Br)cc2)n2ncnc21
Value:=44300nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:CCOc1cccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C
Value:=6500nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21
Value:=15000nM
Source:Homo sapiens
Assay:Induction of p53 in human HCT116 cells coexpressing pp53TA-luc assessed as inhibition of cell proliferation after 8 hrs by firefly/renilla luciferase reporter assay
Type:IC50
SMILES:CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Cl)cc2)n2ncnc21
Value:=9370nM
Source:Homo sapiens
Assay:Induction of p53-Ser15 phosphorylation in human HCT116 cells after 24 hrs
Type:IC50
SMILES:COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1
Value:=1000nM
Source:Homo sapiens
Assay:Induction of p53-Ser15 phosphorylation in human HCT116 cells after 24 hrs
Type:IC50
SMILES:Cc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C
Value:=1000nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:CCC(C)NC(=O)Cn1c(=O)n(Cc2ccc(C(=O)NCc3ccc(C)cc3)cc2)c(=O)c2ccccc21
Value:=15848.9nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:CCn1c(CN2CCCCC2)nc2cc(NC(=O)COc3cc(C)ccc3C(C)C)ccc21
Value:=31622.8nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:COc1ccc(-c2cc(C(F)(F)F)n3nc(C(=O)NCC45CC6CC(CC(C6)C4)C5)cc3n2)cc1
Value:=31622.8nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:CCN(c1ccccc1)S(=O)(=O)c1nnc(NC(=O)c2cccs2)s1
Value:=1258.9nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:Cc1ccc(N2CCN(C(=O)c3cnn(-c4ccc(F)cc4F)c3C3CCN(C(=O)OC(C)(C)C)CC3)CC2)c(C)c1
Value:=12589.3nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:COc1cc(OC)cc(C(=O)Nc2ccc3c(c2)OCCO3)c1
Value:=7943.3nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:COc1ccc2nc(N3CCN(C(=O)C4CC4)CC3)sc2c1
Value:=12589.3nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:CCCCN(CC)CCCNC(=O)C1CCN(c2nc3ccc(CC)cc3s2)CC1
Value:=10000nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:O=C1c2cccc(OCC(=O)N3N=C(c4cccs4)CC3c3ccc(F)cc3)c2CCN1Cc1ccccc1
Value:=3162.3nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:O=S(=O)(NCc1ccccc1)c1ccc2[nH]c3c(c2c1)CCCCC3
Value:=15848.9nM
Source:Homo sapiens
Assay:PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory)
Type:Potency
SMILES:CCCOc1ccc(-c2nc3ccccc3c(=O)o2)cc1
Value:=15848.9nM
Source:Homo sapiens

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the TP53 target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1